Article Details

Arbutus Biopharma Gets Approval to Proceed With IND for Hepatitis B Treatment

Retrieved on: 2021-07-07 11:15:00

Tags for this article:

Click the tags to see associated articles and topics

Arbutus Biopharma Gets Approval to Proceed With IND for Hepatitis B Treatment. View article details on hiswai:

Excerpt

Arbutus Biopharma Corp. said it has received authorization from the U.S. Food and Drug Administration to proceed with its investigational new drug ...

Article found on: www.marketwatch.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up